Edesa Biotech EV/EBIT
Qual é o EV/EBIT de Edesa Biotech?
O EV/EBIT de Edesa Biotech, Inc. é N/A
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em NASDAQ em comparação com Edesa Biotech
O que Edesa Biotech faz?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Empresas com ev/ebit semelhantes a Edesa Biotech
- Telesis Bio Inc tem EV/EBIT de N/A
- Iterum Therapeutics Plc tem EV/EBIT de N/A
- Nuformix Plc tem EV/EBIT de N/A
- Alvo Minerals Ltd tem EV/EBIT de N/A
- NCS Multistage Inc tem EV/EBIT de N/A
- DarioHealth Corp tem EV/EBIT de N/A
- Edesa Biotech tem EV/EBIT de N/A
- Eupraxia Pharmaceuticals tem EV/EBIT de N/A
- QDM International tem EV/EBIT de N/A
- Orion Nutraceuticals Inc tem EV/EBIT de N/A
- Hopefield Ventures Inc tem EV/EBIT de N/A
- Delta Drone SA tem EV/EBIT de N/A
- Sable Resources tem EV/EBIT de N/A